Document is current
Any future updates will be listed below
-
Authors
Kumar, Vineet
LaJevic, Melissa
Pandrala, Mallesh
Jacobo, Sam A.
Malhotra, Sanjay V.
Zabel, Brian A.
- License Information
-
More Information
Article History
Received: 13 November 2018
Accepted: 23 April 2019
First Online: 9 May 2019
Competing Interests
: Dr. Kumar, Dr. LaJevic, Dr. Pandrala, Sam Jacobo, and Dr. Malhotra declare no competing interests. Dr. Zabel is an inventor on US Patent No. #9,265,738 titled, “Small Molecule CMKLR1 Antagonists in Demyelinating Disease” by Graham KL, Zhang JV, Butcher EC, Zabel BA, February 2016. Dr. Zabel is also an inventor in US Patent No. #8,038,992 titled, “Target for Regulating Multiple Sclerosis” by Graham KL, Zabel BA, Butcher EC, October 2011. In both cases, the specific aspects of the manuscript covered in the issued patents relate to the targeting of CMKLR1 with small molecule antagonist α-NETA and its analogs for the prevention and/or treatment of demyelinating disease (e.g. MS).
